Clinical Trials Logo

Filter by:
NCT ID: NCT01321307 Not yet recruiting - Mucositis Clinical Trials

Aphtostomatitis and Mucositis Treatment by Natural Herbal Formula (Sorend®)

Start date: April 2011
Phase: N/A
Study type: Observational

Sorend is a water-based formula, which contains carob, melissa and sage. Elder inhabitants of Israel are known to use carob extract to ease sores in the mouth, due to the tannins which create a complex with various proteins and polysaccharides, thus creating an impenetrable layer covering the sores, allowing spontaneous healing.

NCT ID: NCT01320982 Not yet recruiting - Schizophrenia Clinical Trials

Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder

MAP-S-01
Start date: March 2011
Phase: Phase 3
Study type: Interventional

The objective of the study is to evaluate the efficacy of Pramipexole, Minocycline and Aspirin compared to placebo, as add-on to anti-psychotics in the treatment of patients with schizophrenia.

NCT ID: NCT01319071 Not yet recruiting - Top-level Athletes Clinical Trials

Genetic Polymorphism and Israeli Top-level Athletes

Start date: April 2011
Phase: N/A
Study type: Observational

It is still unknown whether different genetic elements play a role in athletes' ability to create their area of specificity.In a study conducted in our laboratory few years ago, we genotyped 22 genes in 2 athletic groups (endurance and sprinters) and in age and gender matched nonathletic controls. Few of these genes were found to be associated with athletic performance and area of specificity. Since then a few more genes have been found that are related to athletic performance, and our aim in the current study is to expand our research to these new genes which include 3 genetic cascades: genes associated with body fluid balance and homeostasis, genes associated with muscle strength, and genes associated with bioenergy.

NCT ID: NCT01319032 Not yet recruiting - Clinical trials for Genetic Polymorphism Connected to Top-level Swimmers

Genetic Polymorphism and Israeli Top-level Swimmers' Performance and Expertise

Start date: April 2011
Phase: N/A
Study type: Observational

In a study conducted in our laboratory few years ago, we genotyped 22 genes in 2 athletic groups (endurance and sprinters) and in age and gender matched nonathletic controls. Few of these genes were found to be associated with athletic performance and area of specificity. Since then a few more genes have been found that are related to athletic performance, and we intend to study various genes related to 3 genetic cascade: genes associated with body fluid balance and homeostasis, genes associated with muscle strength, and genes associated with bioenergy. The results of this study compared with athletic level will provide deeper insight into the genetic mechanisms involved in performance.

NCT ID: NCT01315470 Not yet recruiting - Infertility Clinical Trials

Use of Granulocyte Colony-stimulating Factor for the Treatment of Recurrent Implantation Failure in IVF Patients

Start date: June 2011
Phase: Phase 1
Study type: Interventional

The investigators use granulocyte colony-stimulating factor (GCSF) for the treatment of recurrent implantation failure in IVF patient with cause unknown or due to thin endometrium. Several studies showed that GCSF improves embryo development and implantation and increase pregnancy rate.

NCT ID: NCT01314456 Not yet recruiting - Prostate Cancer Clinical Trials

3D Recording of a Trans-rectal Prostate Biopsy

Start date: March 2011
Phase: N/A
Study type: Interventional

Prostate biopsy is performed by multiple consecutive biopsy needle insertion into the prostate gland under a trans-rectal ultrasound probe guidance. Today, the performing physician navigates the needle using a momentary 2D ultrasound image (longitudinal and transverse B mode) without any record of the full prostate boundaries or previous biopsies' location. This study's Objectives are to record the trans-rectal biopsy procedure including the initial scan and the needle biopsy location and to modulate a 3D model of the prostate with accurate display the locations of the various biopsies taken during the procedure.

NCT ID: NCT01312688 Not yet recruiting - Sepsis Clinical Trials

Early Goal-directed Therapy and Myocardial Dysfunction

SEPT-MD
Start date: July 2011
Phase: N/A
Study type: Interventional

The cardiovascular system plays a central role in the pathophysiology and prognosis of sepsis, yet the correct hemodynamic management of septic patients is still vigorously debated. Despite guidelines, the use of CVP and PAOP is seriously criticized for inaccurate prediction of fluid requirement. Recently studies showed that early goal-directed therapy (EGDT) aimed at achieving a ScvO2 of ≥70% significantly improved survival of septic shock patients, yet EGDT has not been adopted by all intensivists. The investigators have recently found using 2D echocardiography in 262 patients with severe sepsis or septic shock and treated by the conventional guidelines (without ScvO2) that diastolic dysfunction and reduced stroke volume index are strong independent predictors of mortality. In the present study the investigators intend to test the effect of EGDT on resuscitation, on long term myocardial function and left ventricular volumes and on survival in ICU patients with severe sepsis and septic shock. Patients will be randomized to EGDT (resuscitation directed by ScvO2) or standard of therapy for the first six hours after diagnosis of severe sepsis or septic shock and admission to the ICU. After six hours patients in septic shock will be further monitored with non invasive cardiac output (PiCCO, Pulsion Technologies). All patients will be followed daily by 2D & 3D transthoracic echocardiography with detailed measurements of systolic and diastolic left and right ventricular volumes and functions. Patients in the EGDT group will be compared to the control group for parameters of initial resuscitation (fluid volumes, ScvO2 achieved, inotrope use), initial values from non invasive cardiac output at six hours, interventions required from institution of non invasive cardiac output, early and long term effects on cardiac function and volumes from echo measurements, and mortality. The effectiveness of EGDT will thus be examined in the short and long terms.

NCT ID: NCT01311570 Not yet recruiting - Depression Clinical Trials

Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients

Start date: October 2012
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to assess the therapeutic effect of Buprenorphine in MDD population. The secondary objectives of this study are to assess the therapeutic effect, the feasibility and safety of buprenorphine in a MDD population.

NCT ID: NCT01307514 Not yet recruiting - DIABETES Clinical Trials

Effects of Heating Massaging Vibrating Vicinity of the Insulin Delivery Site

Start date: November 2008
Phase: N/A
Study type: Observational

The aim of this experiment is to test the pharmacodynamics and pharmacokinetics of insulin analogs and their dependence on external and physiological alterations. The investigators plan compare the pharmacodynamics of insulin analog delivery in regular conditions and in the presence of increased perfusion of the delivery site, achieved by way of local warming, movement and topical application of Capsaicin cream. The investigators will also test the effect of local heating and topical application of Capsaicin cream on the post prandial glucose levels following a bolus.

NCT ID: NCT01307163 Not yet recruiting - Liver Transplant Clinical Trials

Systemic Variables in the Saliva of Children Undergoing Liver Transplantation

Start date: January 2008
Phase: N/A
Study type: Observational

Saliva is used nowadays as a significant diagnostic tool due to the latest technological developments. The research compares two experimental groups; children after liver transplantation and a control group. Our objective is to identify from all the parameters that are evaluated, the ones that differ between the two groups. If such parameters will be found and differ statistically, it will be possible to create a non invasive medical examination protocol, which will probably be much more complaint, and being so would help locate individuals in risk groups with the tendency to develop an end-organ liver disease.